Responses to Requests for Proposals supports organizations delivering independent education for healthcare professionals and patients to address knowledge gaps and improve care in ATTR amyloidosis, AHP, and PH1.
Educational Grants - Alnylam Pharmaceuticals support healthcare professionals and patients through independent education on three rare diseases to advance earlier diagnosis, treatment decisions, and disease management.
Alnylam Pharmaceuticals' CME Grants fund independent, evidence-based education for healthcare professionals on ATTR amyloidosis, AHP, and PH1.
Collaborations - Alnylam Pharmaceuticals supports external organizations in joint projects that advance education, ongoing research, and responses to community needs to improve patient health.
Alnylam Pharmaceuticals' Sponsorships fund educational and scientific initiatives advancing research and awareness in ATTR amyloidosis, AHP, and PH1.
AstraZeneca funds independent medical education programs to improve awareness, diagnosis, and treatment knowledge of transthyretin amyloidosis for multidisciplinary healthcare professionals.